Mastoiditis with Streptococcus pneumoniae serotype 19A in one-dose PCV13 vaccinated three-month-old infant
Human Vaccines and Immunotherapeutics, cilt.15, sa.12, ss.2917-2918, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 15 Sayı: 12
- Basım Tarihi: 2019
- Doi Numarası: 10.1080/21645515.2019.1627823
- Dergi Adı: Human Vaccines and Immunotherapeutics
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.2917-2918
- Anahtar Kelimeler: Serotype 19A, mastoiditis, acute otitis media, pneumococcal conjugate vaccine
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Pneumococcal conjugate vaccines (PCV) have been widely used in high-income countries for more than a decade, resulting in a dramatic reduction in pneumococcal disease caused by vaccine serotypes. PCV has been included in Turkey’s National Immunization Programme since 2009 with PCV7 and continued with PCV13 from 2011. We presented a three-month-old infant who developed mastoiditis secondary to S. pneumoniae serotype 19A after acute otitis media.